Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance

Antonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, David Engel, Marjorie Poggi, Susan Van Den Berg, Sjoerd Van Den Berg, Oliver Soehnlein, Holger Winkels, Linda Beckers, Dirk Lievens, Ann Driessen, Pascal Kusters, Erik Biessen, Ruben Garcia-Martin, Anne Klotzsche Von Ameln, Marion Gijbels, Randolph Noelle, Louis Boon, Tilman HackengKlaus Schulte, Aimin Xu, Gert Vriend, Sander Nabuurs, Kyoung Jin Chung, Ko Willems Van Dijk, Patrick C.N. Rensen, Norbert Gerdes, Menno De Winther, Norman L. Block, Andrew V. Schally, Christian Weber, Stefan R. Bornstein, Gerry Nicolaes, Triantafyllos Chavakis, Esther Lutgens

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences